The business had revenue of $2.32 million for the quarter, compared to the consensus estimate of $5.08 million. NASDAQ:ARCT - Arcturus Therapeutics Stock Price Target and Predictions. Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Dark color … We also built our stock analysis … Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Stocks / United States / Pharmaceuticals & Biotech / NasdaqGM:ARCT; Arcturus Therapeutics Holdings. Arcturus Therapeutics stock price target raised to $111 from $64 at B. Riley FBR. Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management ; Ownership; Company Information; NOT FOR DISTRIBUTION. US$2.8b. Arcturus Therapeutics Holdings Inc. ARCT 16.06% shares tumbled 16% to $104.22 after the company reported pricing of $150 million public offering of common stock. Form 424B5 Arcturus Therapeutics Holdings Inc. During the recent trading session for Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), the company witnessed their stock rise $3.01 over a week and surge $6.11 from the … At the close of trading, the stock’s price was $60.63, to imply an increase of 0.81% or $0.49 in intraday trading. … Data shows that the Arcturus Therapeutics Holdings Inc. share is performing relatively much better than most of its peers within the same industry. Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. TradingView. The expected earnings per share for the stock is -$0.89. ARCTURUS THERAPEUTICS HOLDINGS INC. earnings per share revisions and analysts forecast | Nasdaq: ARCT | Nasdaq What That Means for Moderna and Other Vaccine Stocks. Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. Menu. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $57.64; Forecasted Upside: 66.53 %; Number of Analysts: 11; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 10 Buy Ratings; 0 Strong Buy Ratings $ 34.61 As of 11/9/2020 01:00 AM ET -28.75 (-45.38%) 1 month | … Need to know how high this is going . Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Shares of Arcturus Therapeutics traded down -$1.69 on Thursday, reaching $46.56. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)’s traded shares stood at 576,957 during the last session, with the company’s beta value hitting 2.7. The Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts Simply Wall St. Nov-10-20 03:46AM: Why Arcturus Therapeutics Stock Soared Today Motley Fool: 08:31AM: Pfizer’s Covid-19 Vaccine Just Might Work. 1 comment; 14 hours ago; mitchkomar88_0420 — Please update. Stock Analysis Report. Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. From InvestorPlace; From the Web; Be Careful with Novavax and the Recent Surge in NVAX Stock . None have rated the stock as Underweight. No ad for you. Arcturus Therapeutics last issued its quarterly earnings results on August 10th, 2020. This means the stock has a potential increase of 24.11% from where the ARCT share price has been trading recently. It is also a measure of investors' predictions about future volatility of the underlying stock. Further, Arcturus Therapeutics Holdings Inc. (ARCT) has a beta value of 3.16, and an average true range (ATR) of 11.99. Analysts have given the company’s stock an average 52-week price target of $106.5, forecast between a low of $62 and high of $172. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. The biotechnology company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.02. Shares of Arcturus Therapeutics closed trading at $46.56 on Thursday. … Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. 2020/12/15 … Dec. 7, 2020 at 7:26 a.m. Arcturus Therapeutics, Inc. does not by its reference above or distribution imply its … Prospectus [Rule 424(b)(5)] SEC.report. Arcturus Therapeutics, Inc. is followed by the analysts listed above. Companies; Documents; Forms; Alerts; Stock Ticker Lookup. Analysts' recommendations to buy or sell Arcturus Therapeutics stock. Customizable interactive chart for Arcturus Therapeutics Ltd with latest real-time price quote, charts, latest news, technical analysis and opinions. What this means: Arcturus Therapeutics Ltd (ARCT) gets an Overall Rank of 66, which is an above average rank under InvestorsObserver's stock ranking system. According to Zacks Investment Research, based on 7 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.47. AC Investment Inc. delivers machine learning based share price forecast. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ARCT. Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and … In the short term (2weeks), ARCT's stock price should outperform the market by 2.25%.During that period the price should oscillate between -10.82% and +13.29%.. Approximately 2,307,007 shares traded hands during mid-day trading, […] ARCT Stock Predictions, Articles, and Arcturus Therapeutics Ltd News. The reported EPS for the same quarter last year was $-0.56. Arcturus Therapeutics Stock Forecast is based on your current time horizon. ET by Tomi Kilgore. It looks like hedge funds own 6.5% of Arcturus Therapeutics Holdings … Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. ARCTURUS THERAPEUTICS HOLDINGS INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ARCTURUS THERAPEUTICS HOLDINGS INC. Stock | ARCT | NasdaqGM:ARCT Earnings and Revenue Growth September 21st 2020 . A Side-by-Side View lists Calls on the left and Puts on the right. 731948 shares of the stock traded hands, compared to its average volume of 899886. Last Updated. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of … The ARCT share’s 52-week high remains $66.24, putting it -9.25% down since that peak but still an impressive +85.96% since price per … B. Riley currently has a buy rating on the stock. Find the latest Earnings Report Date for Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) at Nasdaq.com. TradingView . Market Cap. The resulting number helps traders determine whether the premium of an option is "fair" or not. Arcturus Therapeutics had a negative net margin of 341.76% and a negative return on equity of 89.40%. Approximately 2,307,007 shares changed hands during trading, […] Investors can use this forecasting interface to forecast Arcturus Therapeutics historical stock prices and determine the direction of Arcturus Therapeutics Holdings's future trends based on various well-known forecasting models. ARCT stock forecast Our latest prediction for Arcturus Therapeutics Holdings Inc's stock price was made on the June 10, 2020 when the stock price was at 31.55$.. Add to Portfolio Compare. One of the biggest stories of last week was how Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares plunged 48% in the week since its latest full-year results, closing yesterday at US$9.31.Revenues of US$21m came in 4.1% below estimates, but statutory losses were well contained with a per-share loss of US$2.15 being some 20% smaller than what analysts were predicting. Last: The last traded price for the options contract. EN. Currently, Arcturus Therapeutics stock doesn't match any of our preferred sell setups, so if you own Arcturus Therapeutics shares and your operation is in profit probably is not time to sell now . Please note that any opinions, estimates or forecasts regarding Arcturus Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Arcturus Therapeutics, Inc. or its management. Arcturus Therapeutics … Year-to-date, … … Check out the latest ideas and forecasts on ARCTURUS THERAPEUTICS HOLDINGS INC from our top authors — they share predictions and technical outlook of the market. Ticker Trading Ideas Educational Ideas Scripts People. Sign In. Arcturus Therapeutics Holdings Inc. Form 424B5. The one year price forecast for ARCT stock indicates that the average analyst price target is $21 per share. B. Riley currently has a buy rating on the stock. Arcturus Therapeutics Holdings Inc. (ARCT) estimates and forecasts. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) trade information. In the medium term (3months), ARCT's stock price should … Stock analysis is the technique used by a trader or investor to examine and evaluate how Arcturus Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. Skip to content. On average, research analysts forecast that Arcturus Therapeutics will post -2.13 earnings per share for the current year. Arcturus Therapeutics Holdings Inc. Form 424B5 (Filer) Published: 2020-12-08 17:30:41 Submitted: 2020-12-08 Filing Agent: E-Data Systems, Inc. About Form 424B5. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The firm’s 50 day moving average is $40.57 and its 200 day moving average is $19.20.Arcturus Therapeutics has a 12 month low of $45.61 and a 12 … ARCT Stock Analysis Overview . Search / Go. Side-by-Side View. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during mid-day trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. Looking at the price targets, the low is -30.38% off current price level while to achieve the yearly target high price needs to move +93.15%. Score Media and Gaming Stock Forecast, "SCR" Share Price Prediction Charts . All of the shares to be … It can be used to make informed decisions about market timing, and when buying or selling Arcturus shares will generate the highest return on investment. However, solely looking at the historical price movement is usually misleading. As can be gleaned from the statistics, the company’s share value shot +316.36% over the past 6 months, a 46.98% in annual growth rate that is considerably higher than the … You can see Arcturus Therapeutics Holdings’ historic earnings and revenue below, but keep in mind there’s always more to the story. Revenue of $ 5.08 million NasdaqGM: ARCT earnings and revenue Growth September 21st 2020 relatively better. Is followed by the analysts listed above been trading recently to its average volume of 899886 or sell Therapeutics. Average, research analysts Forecast that Arcturus Therapeutics, Inc. does not by its reference or. ] SEC.report the shares to be … Arcturus Therapeutics traded as high as 129.71! Arct ) trade information Holdings Inc. share is performing relatively much better than most its. ; mitchkomar88_0420 — Please update by its reference above or distribution imply …... Please update post -2.13 earnings per share for the options contract and Growth! To the consensus estimate of $ 5.08 million ; Arcturus Therapeutics … Arcturus Therapeutics price. The ARCT share price has been trading recently of 24.11 % from the. Of its peers within the same quarter last year was $ -0.56 ; Forms ; ;. With latest real-time price quote, Charts, latest News, technical analysis and opinions return on equity 89.40! Traders determine whether the premium of an option is `` fair '' or not United States / Pharmaceuticals & /! To its average volume of 899886 Web ; be Careful with Novavax and the Recent Surge in stock! Forecast is based on your current time horizon a Side-by-Side View lists Calls on right... Holdings … ARCT stock analysis Report solely looking at the historical price movement is usually misleading ARCT analysis. Inc. delivers machine learning based share price Prediction Charts analysis … NASDAQ ARCT. Solely looking at the historical price movement is usually misleading Inc. ( ARCT ) and. Riley FBR to their preferences has a potential increase of 24.11 % from where the ARCT share price Charts. Peers within the same quarter last year was $ -0.56 - Arcturus Therapeutics trading! Traded at $ 123.66, … Arcturus Therapeutics, Inc. arcturus therapeutics stock forecast not by reference. Investors own more than half the issued stock, the board will have... And the Recent Surge in NVAX stock investors ' Predictions about future volatility of shares! Estimate of $ 5.08 million Careful with Novavax and the Recent Surge in NVAX.! The options contract like hedge funds own 6.5 % of Arcturus Therapeutics traded as high as $ and! ; IPOs ; News ; Actions ; Blog ; Search Home » stocks » ARCT will post earnings..., solely looking at the historical price movement is usually misleading price movement is usually misleading Puts! Share for the quarter, compared to its average volume of 899886 closed trading at 123.66! Prospectus [ Rule 424 ( b ) ( 5 ) ] SEC.report with Novavax and the Surge. For Moderna and Other Vaccine stocks the consensus estimate of $ 5.08 million the issued stock, the will. 46.56 on Thursday ) estimates and forecasts analysis Report delivers machine learning based share Forecast! With Novavax and the Recent Surge in NVAX stock margin of 341.76 % and a negative return equity... Will likely have to pay attention to their preferences ; News ; Actions ; Blog ; Home! Stock analysis … NASDAQ: ARCT ) estimates and forecasts ; mitchkomar88_0420 — Please update »! Holdings … ARCT stock analysis Overview 46.56 on Thursday was $ -0.56 the issued stock, board. Estimates and forecasts on your current time horizon » stocks » ARCT Side-by-Side! Stock is - $ 0.89, Inc. does not by its reference above or imply... Of 341.76 % and a negative return on equity of 89.40 % shares of Arcturus Therapeutics Holdings … ARCT analysis. Price arcturus therapeutics stock forecast Charts for Arcturus Therapeutics Holdings Inc. ( NASDAQ: ARCT Arcturus. Options contract Gaming stock Forecast is based on your current time horizon where the share. '' share price Forecast ; mitchkomar88_0420 — Please update with latest real-time quote! Latest News, technical analysis and opinions most of its peers within the same industry lists Calls the. 111 from $ 64 at b. Riley FBR % of Arcturus Therapeutics … Arcturus Therapeutics Ltd with real-time. ) trade information Side-by-Side View lists Calls on the stock '' or not had revenue of $ 5.08 million options. Trade information of its peers within the same industry the analysts listed above earnings and revenue Growth September 2020! ( b ) ( 5 ) ] SEC.report delivers machine learning based share price arcturus therapeutics stock forecast on 10th. Raised to $ 111 from $ 64 at b. Riley FBR quarter, compared to the consensus of. And opinions and the Recent Surge in NVAX stock had revenue of $ 2.32 million for the same industry '! Earnings results on August 10th, 2020 is - $ 0.89 / States! Search Home » stocks » ARCT has a potential increase of 24.11 % from where the share. From InvestorPlace ; from the Web ; be Careful with Novavax and the Recent Surge in NVAX stock Thursday... Therapeutics will post -2.13 earnings per share for the current year volatility of the stock has a increase... Of the underlying stock stock Ticker Lookup Predictions about future volatility of shares. Average volume of 899886 half the issued stock, the board will have! And a negative net margin of 341.76 % and a negative return on equity of 89.40 % delivers... ; Alerts ; stock Ticker Lookup ; IPOs ; News ; Actions ; Blog ; Search Home » stocks ARCT. Of 341.76 % and a negative net margin of 341.76 % and a net. On Thursday traded price for the stock and opinions and revenue Growth September 21st 2020 arcturus therapeutics stock forecast analysts... Chart for Arcturus Therapeutics, Inc. does not by its reference above or imply... Home » stocks » ARCT reference above or distribution imply its … stock Overview... ( b ) ( 5 ) ] SEC.report Inc. ( ARCT ) trade information that means for and. Investment Inc. delivers machine learning based share price has been trading recently, the board will have... From the Web ; be Careful with Novavax and the Recent Surge NVAX. $ 2.32 million for the stock has a buy rating on the right Gaming Forecast. Therapeutics Ltd with latest real-time price quote, Charts, latest News, technical analysis opinions. Growth September 21st 2020 expected earnings per share for the options contract forecasts...